Market Research Logo

Venezuela Pharmaceuticals & Healthcare Report Q2 2018

Venezuela Pharmaceuticals & Healthcare Report Q2 2018

BMI View:

The pharmaceutical landscape will remain highly challenging for multinational drugmakers and domestic firms inVenezuela. With the country's economic, political and debt crises unlikely to abate in the near future, the poor businessenvironment will keep investment and productive capacity subdued over the short term at least. For multinational drugmakers, theywill remain incentivised to limit their activity in the country and this will continue to have a negative knock-on effect for healthcarespending and national medicine availability.


BMI Industry View
SWOT
Industry Forecast
Patented Drug Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicines Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Americas Pharmaceuticals & Healthcare Risk/Reward Index
Venezuela Pharmaceuticals & Healthcare Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Boehringer Ingelheim
Calox International
Elmor
GlaxoSmithKline
Grupo Farma
Merck & Co
Novartis
Pfizer
Sanofi
Strides Latina (Sumifarma)
Demographic Forecast
Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report